Physician profile
Michael R Rose
NPI 1861593006
$2,506.26
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $219 · 2021: $125 · 2022: $484 · 2023: $367 · 2024: $387 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $839.42 | 2023-2025 | Miebo, Xiidra, Prolensa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $747.71 | 2019-2021 | |
| Oyster Point Pharma, INC. | $234.01 | 2022 | |
| Sun Pharmaceutical Industries INC. | $149.50 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $138.25 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $124.98 | 2022 | |
| Alcon Vision LLC | $116.88 | 2023 | Rocklatan, Simbrinza, Rhopressa |
| Aerie Pharmaceuticals, INC. | $113.96 | 2019 | |
| Amarin Pharma, INC. | $24.29 | 2020 | |
| Orthofix Medical, INC. | $17.26 | 2023 | Physio-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.